GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mitesco Inc (OTCPK:MITI) » Definitions » Debt-to-EBITDA

Mitesco (Mitesco) Debt-to-EBITDA : -1.65 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Mitesco Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Mitesco's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.77 Mil. Mitesco's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. Mitesco's annualized EBITDA for the quarter that ended in Dec. 2023 was $-1.07 Mil. Mitesco's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -1.65.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Mitesco's Debt-to-EBITDA or its related term are showing as below:

MITI' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.22   Med: -0.5   Max: -0.08
Current: -0.14

During the past 13 years, the highest Debt-to-EBITDA Ratio of Mitesco was -0.08. The lowest was -2.22. And the median was -0.50.

MITI's Debt-to-EBITDA is ranked worse than
100% of 420 companies
in the Healthcare Providers & Services industry
Industry Median: 2.575 vs MITI: -0.14

Mitesco Debt-to-EBITDA Historical Data

The historical data trend for Mitesco's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mitesco Debt-to-EBITDA Chart

Mitesco Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 -0.91 -0.78 -2.22 -0.17

Mitesco Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.44 -0.84 -0.31 -0.70 -1.65

Competitive Comparison of Mitesco's Debt-to-EBITDA

For the Health Information Services subindustry, Mitesco's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mitesco's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mitesco's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Mitesco's Debt-to-EBITDA falls into.



Mitesco Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Mitesco's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.767 + 0) / -10.238
=-0.17

Mitesco's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.767 + 0) / -1.072
=-1.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Mitesco  (OTCPK:MITI) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Mitesco Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Mitesco's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Mitesco (Mitesco) Business Description

Traded in Other Exchanges
N/A
Address
18202 Minnetonka Boulevard, Suite 100, Deephaven, MN, USA, 55391
Mitesco Inc is a development stage company who acquires and implements technologies and services to improve the quality of care, reduce cost, and enhance consumer convenience. It is focused on developing a portfolio of companies that provide healthcare technology solutions and the team is adept at deal structures supportive of long term organizational value.
Executives
Lonnie Allen Plunk director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Lawrence M. Diamond director 7535 EAST HAMPDEN AVENUE, SUITE 400, DENVER CO 80231
Phillip J Keller officer: Chief Financial Officer 2323 RING ROAD, ELIZABETHTOWN KY 42701
Sheila Schweitzer director 1200 CAROLINA CIRCLE, VERO BEACH FL 62962
Ingrid Jenny Lindstrom officer: Chief Legal Officer 1100 WILLS PLACE, GOLDEN VALLEY MN 55422
Juan Carlos Iturregui director 5606 ALBIA RD., BETHESDA MD 20816
Faraz Naqvi director 3001 HEARTHSTONE DRIVE, FORT COLLINS CO 80528
Thomas Brodmerkel director 7535 EAST HAMPDEN AVENUE, STE. 400, DENVER CO 80231
Julie R. Smith director 7535 EAST HAMPDEN AVENUE, SUITE 400, DENVER CO 80231
Ron Riewold officer: CHAIRMAN 37 NORTH ORANGE AVE, STE 500, ORLANDO FL 32801
Douglas Cole director C/O AMERICAN BATTERY METALS CORP, 930 TAHOE BLVD, STE 802-16, INCLINE VILLAGE NV 89451
James Philip Crone director, officer: Pres, Interim CFO, Sec, Dir 1355 PEACHTREE STREET, SUITE 1150, ATLANTA GA 30309
Morton James E Iii officer: President 549 VIKINGS LANE, ATLANTIC BEACH FL 32233
Deluca Louis George Jr officer: C.O.O. 194 EDWARDS DR, MABLETON GA 30126
Thomas W. Burnell officer: President and CEO 1355 PEACHTREE STREET, SUITE 1150, ATLANTA GA 30309